Myasthenia gravis exacerbation after melatonin administration: case series from a tertiary referral centre

BACKGROUND: Myasthenia gravis is an autoimmune disease mediated by antibodies against proteins associated with the postsynaptic membrane of the neuromuscular junction. Several drugs may trigger an exacerbation of the disease. Melatonin supplements are widely used for the treatment of insomnia as the...

Descripción completa

Detalles Bibliográficos
Autores principales: Nedkova-Hristova, Velina, Vélez-Santamaría, Valentina, Casasnovas, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640643/
https://www.ncbi.nlm.nih.gov/pubmed/33148186
http://dx.doi.org/10.1186/s12883-020-01975-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640643/
https://www.ncbi.nlm.nih.gov/pubmed/33148186
http://dx.doi.org/10.1186/s12883-020-01975-y

Ejemplares similares